Evidence map›Paper›PMID 30869835›Full record

ArticleThe FEBS journal2019

Differential regulation of myc homologs by Wnt/β-Catenin signaling in the early metazoan Hydra.

Markus Hartl, Stella Glasauer, Sabine Gufler, Andrea Raffeiner, Kane Puglisi, Kathrin Breuker, Klaus Bister, Bert Hobmayer

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A pan-metazoan concept for adult stem cells: the wobbling Penrose landscape.Biological reviews of the Cambridge Philosophical Society · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. MYC Analysis in Cancer and Evolution.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  11. Bacteria- and temperature-regulated peptides modulate β-catenin signaling inProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Markus HartlInstitute of Biochemistry, University of Innsbruck, Austria.
Stella GlasauerCenter for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Austria.
Sabine GuflerCenter for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Austria.
Andrea RaffeinerInstitute of Biochemistry, University of Innsbruck, Austria.
Kane PuglisiInstitute of Biochemistry, University of Innsbruck, Austria.
Kathrin BreukerCenter for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Austria.
Klaus BisterInstitute of Biochemistry, University of Innsbruck, Austria.ORCID 0000-0001-6545-5653
Bert HobmayerCenter for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Austria.
Universität Innsbruck · AT

Funding

Austrian Academy of SciencesAustrian Science Fund P20734Austrian Science Fund P23652Austrian Science Fund P27347Austrian Science Fund FWF P 23652Austrian Science Fund FWF P 27347University of Innsbruck
6 · The paper itself

Abstract

The c-Myc protein is a transcription factor with oncogenic potential controlling fundamental cellular processes. Homologs of the human c-myc protooncogene have been identified in the early diploblastic cnidarian Hydra (myc1, myc2). The ancestral Myc1 and Myc2 proteins display the principal design and biochemical properties of their vertebrate derivatives, suggesting that important Myc functions arose very early in metazoan evolution. c-Myc is part of a transcription factor network regulated by several upstream pathways implicated in oncogenesis and development. One of these signaling cascades is the Wnt/β-Catenin pathway driving cell differentiation and developmental patterning, but also tumorigenic processes including aberrant transcriptional activation of c-myc in several human cancers. Here, we show that genetic or pharmacological stimulation of Wnt/β-Catenin signaling in Hydra is accompanied by specific downregulation of myc1 at mRNA and protein levels. The myc1 and myc2 promoter regions contain consensus binding sites for the transcription factor Tcf, and Hydra Tcf binds to the regulatory regions of both promoters. The myc1 promoter is also specifically repressed in the presence of ectopic Hydra β-Catenin/Tcf in avian cell culture. We propose that Hydra myc1 is a negative Wnt signaling target, in contrast to vertebrate c-myc, which is one of the best studied genes activated by this pathway. On the contrary, myc2 is not suppressed by ectopic β-Catenin in Hydra and presumably represents the structural and functional c-myc ortholog. Our data implicate that the connection between β-Catenin-mediated signaling and myc1 and myc2 gene regulation is an ancestral metazoan feature. Its impact on decision making in Hydra interstitial stem cells is discussed.

Indexed as

Animalsbeta CateninBody PatterningGene Expression RegulationHydraProto-Oncogene Proteins c-mycTranscriptional ActivationTranscription FactorsWnt Signaling Pathwaybeta CateninProto-Oncogene Proteins c-mycTranscription Factorscnidariandevelopmentgene regulationoncogenesignal transduction

Identifiers

PMID30869835
PMCPMC6618008
OpenAlexW2922160423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.